INC Research Appoints James Taylor Vice President, Clinical Development
(Thomson Reuters ONE) -
25-year veteran of the life sciences industry brings extensive large pharma
experience
encompassing CRO oversight, project management and operational delivery
Raleigh, N.C., March 11, 2013 - INC Research, LLC, a therapeutically focused
global clinical research organization (CRO) with a Trusted Process® for
delivering reliable results, today announced James Taylor has joined the Company
as Vice President, Clinical Development. Mr. Taylor joins INC Research from
Pfizer, where he served most recently as Vice President, Global Clinical Trial
management. In his new role, Mr. Taylor will serve as the primary liaison to
biopharmaceutical customers, vendors and investigative sites for the Company's
General Medicine Business Unit.
"Jim is an accomplished leader with global experience across all phases of
complex enterprise operations involving the execution of clinical trials," said
Jamie Macdonald, CEO, INC Research. "Having worked in large pharma for many
years, he brings a strong customer perspective, which allows him to anticipate
our customers' needs and communicate their requirements more effectively. This
insight, along with his unique blend of business and operational expertise, will
be instrumental in further strengthening our relationships to drive innovation
and accelerate decision making in clinical programs."
Mr. Taylor has more than 25 years of experience in the life sciences industry,
including 15 years overseeing and executing global clinical trials. He also
brings significant functional expertise in CRO selection and start-up,
investigative site performance and contracting, CRO oversight and risk
management, and alliance management from his experience at Pfizer where he
oversaw the design, planning and execution of late stage clinical trials. Mr.
Taylor's experience also includes serving as Global Head of outsourcing
management at Sanofi-Aventis, where he was responsible for driving the global
outsourcing strategy for its drug innovation and approval business unit.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development programs
of the highest integrity. Pharmaceutical and biotechnology companies look to INC
Research for a complete range of customized Phase I through Phase IV programs in
all therapeutic areas and innovative pediatric and women's health trials. The
company's Trusted Process(®) methodology and therapeutic foresight lead
customers to more confident, better-informed drug and device development
decisions. INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com or follow us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1684357]
Unternehmensinformation / Kurzprofil:
Datum: 11.03.2013 - 14:46 Uhr
Sprache: Deutsch
News-ID 238054
Anzahl Zeichen: 3630
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 208 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Appoints James Taylor Vice President, Clinical Development"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
